(Q41750369)

8 October 2017

3 references

8 April 2021

3 October 2022

Lipid mediators in inflammatory disorders (English)

1 reference

8 October 2017

0 references

inflammation mediators

1 reference

8 April 2021

A Heller

1

1 reference

8 October 2017

T Koch

series ordinal

2

1 reference

8 October 2017

J Schmeck

series ordinal

3

1 reference

8 October 2017

K van Ackern

series ordinal

4

1 reference

8 October 2017

1 April 1998

3 references

8 October 2017

8 April 2021

3 October 2022

3 references

8 October 2017

8 April 2021

3 October 2022

55

1 reference

8 October 2017

4

1 reference

8 October 2017

487-496

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199855040-00001

8 October 2017

0 references

cites work

The effect of leukotriene synthesis inhibitors in models of acute and chronic inflammation

1 reference

12 December 2020

Effect of a leukotriene B4 receptor antagonist, LY293111, on allergen induced responses in asthma

1 reference

12 December 2020

Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs

1 reference

12 December 2020

Inhibition of ex vivo neutrophil activation by oral LY293111, a novel leukotriene B4 receptor antagonist

1 reference

12 December 2020

Slow reacting substances of anaphylaxis: Identification of leukotrienes C-1 and D from human and rat sources

1 reference

12 December 2020

In vivo inhibition of plasma protein leakage and Salmonella enteritidis-induced mortality in the rat by a specific paf-acether antagonist: BN 52021.

1 reference

12 December 2020

Differential regulation of cytokine and cytokine receptor genes by PAF, LTB4 and PGE2.

1 reference

12 December 2020

DTTX30, a combined thromboxane receptor antagonist and thromboxane synthetase inhibitor, prevents coronary thrombosis in anesthetized dogs

1 reference

12 December 2020

The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group

1 reference

12 December 2020

Phospholipase A2 inhibition decouples lung injury from gut ischemia-reperfusion

1 reference

12 December 2020

Randomized, double-blind phase II trial of Lexipafant, a platelet-activating factor antagonist, in human acute pancreatitis

1 reference

12 December 2020

Effects of a potent platelet-activating factor antagonist, SR27417A, on allergen-induced asthmatic responses

1 reference

12 December 2020

Human neutrophil chemotactic and degranulating activities of leukotriene B5 (LTB5) derived from eicosapentaenoic acid.

1 reference

12 December 2020

The Pivotal Role of 5-Lipoxygenase Products in the Reaction of Aspirin-sensitive Asthmatics to Aspirin

1 reference

12 December 2020

Clinical activity of leukotriene inhibitors.

1 reference

12 December 2020

COX-2, HO NO! Cyclooxygenase-2, heme oxygenase and nitric oxide synthase: their role and interactions in inflammation. BIRAs Symposium, Saint Bartholomew's Hospital, London, 26 April 1996

1 reference

12 December 2020

Inhaled prostacyclin (PGI2) versus inhaled nitric oxide in adult respiratory distress syndrome.

1 reference

12 December 2020

Fish oil fatty acids and cardiovascular function: epidemiology and biochemical mechanisms

1 reference

12 December 2020

Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects

1 reference

12 December 2020

Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: a randomized, double-blind, placebo-controlled, multicenter clinical trial. BN 52021 Sepsis Study Group.

1 reference

12 December 2020

Meloxicam: selective COX-2 inhibition in clinical practice

1 reference

12 December 2020

Effects of a PAF antagonist, Y-24180, on bronchial hyperresponsiveness in patients with asthma

1 reference

12 December 2020

Fatty acid composition of the plasma lipids in Greenland Eskimos

1 reference

12 December 2020

Treatment of rheumatoid arthritis with platelet activating factor antagonist BN 50730

1 reference

12 December 2020

The effects of N-3 polyunsaturated fatty acids on the generation of platelet-activating factor-acether by human monocytes

1 reference

12 December 2020

Alteration of n-3 fatty acid composition in lung tissue after short-term infusion of fish oil emulsion attenuates inflammatory vascular reaction.

1 reference

12 December 2020

Cellular and topical in vivo inflammatory murine models in the evaluation of inhibitors of phospholipase A2.

1 reference

12 December 2020

Characterization of leukotriene B3: comparison of its biological activities with leukotriene B4 and leukotriene B5 in complement receptor enhancement, lysozyme release and chemotaxis of human neutrophils

1 reference

12 December 2020

Prostaglandin I3 is formed in vivo in man after dietary eicosapentaenoic acid

1 reference

12 December 2020

Control of inflammatory processes by cell-impermeable inhibitors of phospholipase A2

1 reference

12 December 2020

Anti-inflammatory effect of a PAF receptor antagonist and a new molecule with antiproteinase activity in an experimental model of acute urate crystal arthritis

1 reference

12 December 2020

A selective cyclooxygenase 2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells.

1 reference

12 December 2020

Analgesic activity of the novel COX-2 preferring NSAID, meloxicam in mono-arthritic rats: Central and peripheral components

1 reference

12 December 2020

PAF modulates eicosanoids and TNF release in immune-complex arthritis in rats

1 reference

12 December 2020

Recent insights into the structure, function and biology of cPLA2.

1 reference

12 December 2020

The effect of topical application of the platelet-activating factor-antagonist, Ro 24-0238, in psoriasis vulgaris--a clinical and immunohistochemical study

1 reference

12 December 2020

Treatment with the platelet-activating factor antagonist TCV-309 in patients with severe systemic inflammatory response syndrome: a prospective, multi-center, double-blind, randomized phase II trial

1 reference

12 December 2020

Effect of platelet-activating factor receptor antagonism on endotoxin-induced lung dysfunction in awake sheep

1 reference

12 December 2020

Phospholipase A2--a structural review

1 reference

12 December 2020

10.2165/00003495-199855040-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

8 October 2017

0 references

0 references

1 reference